Home  >  Products  >  LGALS13 (lectin, galactoside-binding, soluble, 13) Blocking Peptide (the N terminal of LGALS13)(100ug)
LGALS13 (lectin, galactoside-binding, soluble, 13) Blocking Peptide (the N terminal of LGALS13)(100ug)

LGALS13 (lectin, galactoside-binding, soluble, 13) Blocking Peptide (the N terminal of LGALS13)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LGALS13 Antibody(ARP42376_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP42376
Size: 100ug
Weight: 16kDa
Gene: 29124
Format: Lyophilized powder
Target: Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. The protein encoded by this gene has lysophospholipase activity. It is composed of two identical subunits which are held together by disulfide bonds. This protein has structural similarity to several members of the beta-galactoside-binding S-type lectin family.
Alternative names: GAL13; PLAC8; PP13
See Full Product Listings >